EVOKE PHARMA INC's ticker is and the CUSIP is 30049G954. A total of 3 filers reported holding EVOKE PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | 0.0% | 3,100 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 3,100 | +121.4% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 1,400 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -83.3% | 1,400 | +3788.9% | 0.00% | – |
| Q1 2021 | $6,000 | – | 36 | +1700.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 2 | -94.7% | 0.00% | – |
| Q3 2020 | $17,000 | – | 38 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,500 | $3,000 | 0.00% |
| SIMPLEX TRADING, LLC | 1,400 | $1,000 | 0.00% |